Item 1.(a). | Name of Issuer |
Coherus BioSciences, Inc. (the “Company”)
(b). Address of Issuer’s Principal Executive Offices:
333 Twin Dolphin Drive, Suite 600
Redwood City, CA 94065
Item 2(a). | Name of Person Filing |
Daiichi Sankyo Company, Limited
Item 2(b). | Address of Principal Business Office |
The principal business office is:
3-5-1, Nihonbashi-honcho,Chuo-ku, Tokyo103-8426, Japan
Daiichi Sankyo Company, Limited is a Japanese corporation.
Item 2(d). | Title of Class of Securities: |
Common Stock, par value $0.0001 per share (the “Common Stock”)
19249H103
Item 3. | If this statement is filed pursuant to Rule13d-1(b), or13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
(a) Amount beneficially owned:
As of December 31, 2018, Daiichi Sankyo Company, Limited beneficially owns 0 shares of Common Stock of the Company.
(b) Percent of class:
0%
Page 3